John T. Curnutte is President & VP at PORTOLA PHARMACEUTICALS INC (PTLA). They have made 3 open-market trades across 1 company since 2014, most recently 2019-05-20.
CIK 0001269021
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PTLA | 104,977 | $1.9M |
Shares reported on the most recent Form 4, priced at the 2019-05-21 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PTLA | SELL | 2017-07-18 | 2017-07-20 | $65.00 | $650K | -6.8% | -15.3% | -23.3% |
| PTLA | SELL | 2017-06-26 | 2017-06-28 | $57.46 | $2.9M | +11.4% | +17.0% | -6.1% |
| PTLA | SELL | 2017-06-26 | 2017-06-28 | $57.88 | $3.5M | +11.4% | +17.0% | -6.1% |
| PTLA | SELL · 10b5-1 | 2015-07-15 | 2015-07-15 | $50.00 | $500K | -25.1% | -4.2% | -4.2% |
| PTLA | SELL · 10b5-1 | 2015-06-22 | 2015-06-22 | $47.50 | $475K | -25.1% | -4.2% | -4.2% |
| PTLA | SELL · 10b5-1 | 2015-06-16 | 2015-06-17 | $45.00 | $450K | -25.1% | -4.2% | -4.2% |
| PTLA | SELL · 10b5-1 | 2015-05-29 | 2015-05-29 | $42.50 | $425K | -25.1% | -4.2% | -4.2% |
| PTLA | SELL · 10b5-1 | 2015-05-28 | 2015-05-28 | $40.30 | $403K | -25.1% | -4.2% | -4.2% |
| PTLA | SELL · 10b5-1 | 2015-02-23 | 2015-02-23 | $40.00 | $400K | -25.1% | -4.2% | -4.2% |
| PTLA | SELL · 10b5-1 | 2015-02-18 | 2015-02-18 | $37.50 | $375K | -25.1% | -4.2% | -4.2% |
| PTLA | SELL · 10b5-1 | 2015-02-17 | 2015-02-17 | $35.00 | $350K | -25.1% | -4.2% | -4.2% |
| PTLA | SELL · 10b5-1 | 2015-02-13 | 2015-02-13 | $32.50 | $325K | -25.1% | -4.2% | -4.2% |
| PTLA | SELL · 10b5-1 | 2014-06-17 | 2014-06-19 | $28.33 | $850K | -25.1% | -4.2% | -4.2% |
| PTLA | SELL · 10b5-1 | 2014-06-16 | 2014-06-16 | $26.00 | $260K | -25.1% | -4.2% | -4.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.